Statera Biopharma, Inc. Quarterly Current Ratio in % from Q1 2012 to Q3 2022

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Statera Biopharma, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q3 2022.
  • Statera Biopharma, Inc. Current Ratio for the quarter ending September 30, 2022 was 12.4 %.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2022 12.4 Sep 30, 2022
Q2 2022 36.6 Jun 30, 2022
Q4 2020 144 -163 -53.1% Dec 31, 2020
Q3 2020 327 -65.5 -16.7% Sep 30, 2020
Q2 2020 289 -89.7 -23.7% Jun 30, 2020
Q1 2020 249 -143 -36.5% Mar 31, 2020
Q4 2019 307 -86.3 -21.9% Dec 31, 2019
Q3 2019 392 -1.3 -0.33% Sep 30, 2019
Q2 2019 379 -44.1 -10.4% Jun 30, 2019
Q1 2019 392 -62 -13.7% Mar 31, 2019
Q4 2018 394 -95.8 -19.6% Dec 31, 2018
Q3 2018 393 -115 -22.6% Sep 30, 2018
Q2 2018 423 -117 -21.7% Jun 30, 2018
Q1 2018 454 -26.9 -5.6% Mar 31, 2018
Q4 2017 489 +39.2 +8.7% Dec 31, 2017
Q3 2017 508 +98.6 +24.1% Sep 30, 2017
Q2 2017 540 +223 +70.2% Jun 30, 2017
Q1 2017 481 +269 +127% Mar 31, 2017
Q4 2016 450 +308 +216% Dec 31, 2016
Q3 2016 409 +313 +326% Sep 30, 2016
Q2 2016 317 +249 +361% Jun 30, 2016
Q1 2016 212 +102 +93.2% Mar 31, 2016
Q4 2015 142 -20.9 -12.8% Dec 31, 2015
Q3 2015 96 -103 -51.8% Sep 30, 2015
Q2 2015 68.8 -121 -63.8% Jun 30, 2015
Q1 2015 110 -55.7 -33.7% Mar 31, 2015
Q4 2014 163 +10.7 +7.01% Dec 31, 2014
Q3 2014 199 +25.8 +14.9% Sep 30, 2014
Q2 2014 190 +25.7 +15.6% Jun 30, 2014
Q1 2014 165 -30.3 -15.5% Mar 31, 2014
Q4 2013 153 -77.4 -33.6% Dec 31, 2013
Q3 2013 173 -69.2 -28.5% Sep 30, 2013
Q2 2013 165 -149 -47.5% Jun 30, 2013
Q1 2013 196 -111 -36.1% Mar 31, 2013
Q4 2012 230 Dec 31, 2012
Q3 2012 242 Sep 30, 2012
Q2 2012 314 Jun 30, 2012
Q1 2012 306 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.